Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic

▴ Genome & Company receives FDA IND clearance for GEN001
Asia's first company to sponsor clinical trial of combination therapy of anti-cancer microbiome and anti-PD1/anti-PD-L1 drug

 Genome & Company, a biotechnology company developing innovative therapeutics in immune-oncology,announced today that the United States (US) Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for GEN-001 for combination treatment with avelumab (BAVENCIO®) in patients with solid cancers. Avelumab is an anti-PD-L1 antibody co-developed and co-commercialized by Merck KGaA, Darmstadt, Germany and Pfizer Inc.

With this clearance, Genome & Company will be the first Asian company to initiate a first-in-human trial of anti-cancer microbiome and anti-PD1/anti-PD-L1 combination treatment as a sole sponsor. The phase 1/1b clinical trial will be initiated at the US clinical sites and the first patient is expected to be enrolled within this year.

"IND clearance from FDA for our first anti-cancer microbiome therapeutic GEN-001 is a very significant milestone as it will transition Genome & Company into a clinical-stage biotechnology company. We hope to add meaningful value and advancement in the microbiome and immuno-oncology industry with our combinational approach to cancer patients who have progressed on prior anti-PD1/anti-PD-L1 therapy," said Dr. Hansoo Park, Chief Technical Officer of Genome & Company.

Dr. Jisoo Pae, CEO of Genome & Company further quoted, "This IND approval is a meaningful corporate milestone and a critical step forward to achieving new arrangements in strategic partnering. We are indeed looking forward to further investigate how our clinical data will be translated into our cancer patients. I thank all the members and partners of Genome & Company for dedicating themselves to accomplishing this milestone."

In January this year, Genome & Company had entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc. to evaluate the safety, tolerability, biological and clinical activities of GEN-001 therapy in combination with avelumab in multiple cancer indications. The combination trial is designed to be a first-in-human study including dose escalation and expansion cohorts to evaluate the safety and preliminary efficacy.

Tags : #Genome #Company #FDA #clearance #Anticancer #Microbiome #Therapeutic

About the Author


Team Medicircle

Related Stories

03 Apr

University of Manchester invites applications for MA Social Anthropology

The University of Manchester is inviting applications from Indian students for their MA in Social Anthropology for the 2025 session.

View
27 Mar

BluHeat by Nysh.in Launches Innovative Cough Decongestion Patches

Say goodbye to persistent cough and embrace the soothing relief you deserve with BluHeat Cough Decongestion Patches—your natural ally for a more comfortable day and peaceful night's rest.

View
26 Feb

Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks So

Will the government take responsibility, or will affected families be left fighting a lonely legal battle? The coming weeks will determine the course of justice for those who lost loved ones in the fight against COVID-19.

View
16 Jan

Could Engineered Cells Be the Cure-All Medicine We’ve Been Waiting For?

This innovation holds the promise of a future where medicine is not just reactive but proactive, where treatments are not only effective but also tailored to individual needs.

View
14 Jan

India’s Surgical Infection Scandal: How Hospitals Are Falling Short

By addressing the root causes and implementing evidence-based solutions, India can significantly reduce SSI rates and improve surgical outcomes.

View
06 Jan

Silent Invader: India’s First Encounters with Human Metapneumovirus (HMPV)

As the world continues to battle various respiratory illnesses, public health efforts must focus on prevention, timely diagnosis, and comprehensive care

View
02 Jan

Antibiotics Are Not Always the Answer: Understanding Viral Infections and Responsible Medication Use

The next time you catch a cold or flu, remember that antibiotics won’t help. Instead, focus on supporting your immune system and seek guidance from a healthcare professional.

View
11 Dec

TB-Free India by 2025: Bold Vision or Achievable Reality?

The fight against TB is far from over, but India’s progress under the National TB Elimination Programme offers hope.

View
05 Dec

Life or Death: A New Breakthrough in Detecting Sepsis Before It’s Too Late

As healthcare continues to advance, innovations like this remind us of the power of science to save lives and bring hope to those who need it most.

View
14 Nov

Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better Health

By embracing simple, consistent movements, each one of us has the power to boost our health, reduce our risk of disease, and live a longer, happier life.

View

-Advertisements-




Trending Now

Shattering Boundaries in Gynecological Surgery: Dr. Manjula Anagani Pioneers the Hugo™ RAS System in Asia-PacificApril 12, 2025
Moscow Scientists Develop Advanced Liver Phantom for Radiologists TrainingApril 11, 2025
Sightsavers India and GSVM Medical College, Kanpur Partner to Strengthen Ophthalmology Training Through Infrastructure Development and Skill BuildingApril 11, 2025
Sweating to Death: The Dark Side of India's Blistering SummerApril 10, 2025
When Zoning Out Makes You Smarter: The Surprising Truth About Mental DriftApril 10, 2025
Parkinson's Disease: A Growing Concern with Early Onset Cases Rising in IndiaApril 10, 2025
When the Womb Turns Against the Mind: The Shocking Cost of Gestational DiabetesApril 10, 2025
Introducing Atlan® A100 - Dräger’s Latest Innovation in Anaesthesia WorkstationsApril 10, 2025
April 10, 2025
Hinduja Foundation and Gulf Oil Lubricants India Ltd. Install 500 LPH Water ATM in Chotila, Rajkot to Provide Safe Drinking Water for Communities and TruckersApril 10, 2025
Our Brain's Hunger Games: How Mental Cravings Attack ImmunityApril 09, 2025
Inhale Anxiety, Exhale Joy: Is Air Pollution Ruining Mental Health?April 09, 2025
Are You Slowly Killing Your Brain: Habits That Steal Your Memory, Mood, and Mental StrengthApril 09, 2025
Baby & Mom Retail Launches it's New Healthcare Equipment Brand CORVELLApril 09, 2025
Wellbeing Nutrition unveils a new campaign with their Brand Ambassador, Sharvari, Celebrating the power of “Beauty Within”April 09, 2025
Given the rise in heart attack cases in womenApril 08, 2025
CARE Hospitals Marks World Health Day 2025 with ‘Walk for a Healthy Beginning’ at CharminarApril 08, 2025
Cancer, Obesity, Mental Health, India’s top health concerns: Ipsos Health Service Report 2024 April 08, 2025
Why Loneliness Might Be the Real Reason You're Always Falling SickApril 08, 2025
Is Your Beverage Choice Secretly Harming Your Mind?April 08, 2025